Cuffless blood pressure technologies in wearable devices show promise to transform care
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 1-May-2026 02:15 ET (1-May-2026 06:15 GMT/UTC)
Long-term heart disease risk among women diagnosed with uterine fibroids was more than 80% higher than in women without uterine fibroids, according to a 10-year study of more than 2.7 million U.S. women.
The Wearable Imaging for Transforming Elderly Care (WITEC) project, led by SMART in collaboration with MIT, NTU, NUS and Tan Tock Seng Hospital, is developing the world’s first wearable ultrasound imaging system for continuous, real-time monitoring of chronic conditions such as hypertension and heart failure. Supported by advanced tools like Southeast Asia’s first sub-micrometre 3D printer and cutting-edge ultrasonic imaging technology, WITEC aims to shift healthcare from hospital-based interventions to proactive, home-based care, enabling earlier detection, personalised diagnosis and improved patient outcomes.
A new study among more than 1,500 British adolescents is the first in the world to assess the association between familial cardiometabolic diseases and the offspring’s risk of premature heart damage by early adulthood. The study was conducted in collaboration between the Rutgers Robert Wood Johnson Medical School in the US, the Universities of Bristol and Exeter in the UK, and the University of Eastern Finland. The results were published in the European Journal of Preventive Cardiology.
Cardiac arrest vs. heart attacks: Who is at risk
Researchers have published a comprehensive review exploring the critical role of the "immune microenvironment" in the progression of major chronic diseases. The study details how interactions between immune cells, cytokines, and the extracellular matrix contribute to conditions such as diabetes, cardiovascular disease, and cancer. The review emphasizes that targeting this microenvironment offers promising new avenues for diagnosis and immunotherapy, potentially shifting the paradigm of chronic disease management.
Primary malignant pericardial mesothelioma (PMPM) is an exceptionally rare and aggressive tumor originating in the lining of the heart. Due to its ambiguous symptoms and lack of specific guidelines, misdiagnosis is common and survival rates are low. A new expert consensus, published in the journal Med Research, synthesizes multicenter clinical expertise to establish the first standardized protocols for PMPM. The consensus highlights the necessity of multimodal imaging, molecular pathology, and the emerging role of immunotherapy in extending patient survival.
With a four-year, $3.2 million grant from the National Institutes of Health, a team from Pen State College of Medicine will develop a small, durable ventricular assist device (VAD) designed specifically for young, growing children between the ages of one and 11 years old. Currently, there are no heart pumps approved for long-term use for this age group. The device, called the PSU Child VAD, could provide long-term support for children with heart failure while waiting for a heart transplant, greatly improving quality of life and outcomes.